Retour
Fourchette du Jour
9,63 €
10,04 €
Fourchette 52 Semaines
6,00 €
11,31 €
Volume
7 240 678
Moyenne 50J / 200J
7,53 €
/
7,94 €
Clôture Précédente
9,70 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 7,8 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 30,2 | 3,8 |
| Rev Growth 5Y % | 53,6 | 10,0 |
| D/E | — | 0,2 |
Points Clés
Revenue grew 53,60% annually over 5 years — strong growth
Net margin of 30,16% shows strong profitability
Generating 327,41M in free cash flow
P/E of 7,80 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 40,50%
Cash machine — converts 124,09% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
53,60%
Revenue (1Y)94,10%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC71,40%
Net Margin30,16%
Op. Margin38,98%
Sécurité
Debt / Equity
N/A
Current Ratio2,06
Interest Coverage4,32
Valorisation
P/E Ratio
7,80
P/B RatioN/A
EV/EBITDA7,17
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 94,10% | Revenue Growth (3Y) | 62,47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 53,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 874,84M | Net Income (TTM) | 263,86M |
| ROE | N/A | ROA | 51,32% |
| Gross Margin | 97,82% | Operating Margin | 38,98% |
| Net Margin | 30,16% | Free Cash Flow (TTM) | 327,41M |
| ROIC | 71,40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,06 |
| Interest Coverage | 4,32 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 7,80 | P/B Ratio | N/A |
| P/S Ratio | 2,35 | PEG Ratio | -0,02 |
| EV/EBITDA | 7,17 | Dividend Yield | 0,00% |
| Market Cap | 2,06B | Enterprise Value | 2,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 874,84M | 450,71M | 331,41M | 270,83M | 157,17M |
| Net Income | 263,86M | -88,88M | -226,54M | -247,12M | -184,06M |
| EPS (Diluted) | 1,21 | -0,43 | -1,18 | -1,33 | -1,03 |
| Gross Profit | 855,76M | 438,23M | 326,75M | 264,23M | 149,91M |
| Operating Income | 340,99M | -2,54M | -103,71M | -148,44M | -177,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 514,16M | 490,42M | 516,96M | 550,00M | 588,15M |
| Total Liabilities | 633,31M | 966,35M | 972,49M | 844,60M | 695,14M |
| Shareholders' Equity | -119,15M | -475,93M | -455,53M | -294,60M | -106,99M |
| Total Debt | 477,33M | 841,42M | 825,15M | 741,45M | 593,24M |
| Cash & Equivalents | 89,74M | 104,92M | 110,64M | 304,77M | 504,39M |
| Current Assets | 404,35M | 421,97M | 495,97M | 516,50M | 566,14M |
| Current Liabilities | 196,07M | 160,38M | 149,99M | 105,51M | 103,72M |